Health
New combination therapy could help fight difficult-to-treat cancers with common mutations – EurekAlert
UCLA scientists describe a new combination therapy that suppresses the MAPK pathway by holding cancer-driving proteins in a death grip. This combination of two…
LOS ANGELES — Scientists have long known that therapies that target the cancer-driving MAPK pathway are only effective in a handful of cancers with specific mutations in a cancer gene called BRAF, and these cancers that initially respond to the therapy often end up developing resistance to the treatment, resulting in relapse for many patients.
Now, scientists at the UCLA Jonsson Comprehensive Cancer Center describe a new combination therapy that suppresses the MAPK pathway by holding cancer-driving…
-
Business24 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News23 hours agoQueensland government to review greenhouse gas emission reduction targets
-
Noosa News22 hours agoAnother All-Star Cast, Another Tale of Family Chaos: The Trailer for Wes Anderson’s ‘The Phoenician Scheme’ Is Here
-
Business21 hours agoshould I buy hedged or unhedged ASX US-focused ETFs?